Detalhe da pesquisa
1.
Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer.
Oncologist
; 28(4): 366-e224, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519763
2.
Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer.
Clin Genitourin Cancer
; 10(1): 15-20, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22130294
3.
Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis.
J Clin Oncol
; 30(35): 4416-26, 2012 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23150697
4.
Arterial thromboembolism in cancer patients treated with cisplatin: a systematic review and meta-analysis.
J Natl Cancer Inst
; 104(23): 1837-40, 2012 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23093559
5.
Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer.
Clin Med Insights Oncol
; 5: 163-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21695098
6.
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy.
Clin Genitourin Cancer
; 9(1): 27-30, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21700509